NUVL

Nuvalent, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$105.43

Market Cap

$7.72B

Beta

1.32

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-50.00%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.57%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for NUVL.